Works by Zhang, Ruiqi

Results: 196
    1

    Electric Field Inhomogeneity in Colloidal QD‐LEDs.

    Published in:
    Advanced Optical Materials, 2025, v. 13, n. 19, p. 1, doi. 10.1002/adom.202500058
    By:
    • Srinivasan, Shreyas;
    • Zhang, Ruiqi;
    • Dillender, Mike;
    • Nguyen, Thienan;
    • Laitz, Madeleine;
    • Kim, Taehyung;
    • Kim, Kwang‐Hee;
    • Kim, Tae‐Gon;
    • Bawendi, Moungi;
    • Bulović, Vladimir
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Significant reduction in chronic kidney disease progression with sodium‐glucose cotransporter‐2 inhibitors compared to dipeptidyl peptidase‐4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2138, doi. 10.1111/dom.14799
    By:
    • Idris, Iskandar;
    • Zhang, Ruiqi;
    • Mamza, Jil B.;
    • Ford, Mike;
    • Morris, Tamsin;
    • Banerjee, Amitava;
    • Khunti, Kamlesh
    Publication type:
    Article
    11

    Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2207, doi. 10.1111/dom.14437
    By:
    • Idris, Iskandar;
    • Zhang, Ruiqi;
    • Mamza, Jil Billy;
    • Ford, Mike;
    • Morris, Tamsin;
    • Banerjee, Amitava;
    • Khunti, Kamlesh
    Publication type:
    Article
    12

    Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Banerjee, Amitava;
    • Kim, Dae Jung;
    • Norhammar, Anna;
    • Eriksson, Jan W.;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Ha, Kyoung Hwa;
    • Kossack, Nils;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    13

    Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Norhammar, Anna;
    • Haller, Hermann;
    • Linssen, Gerard C.M.;
    • Banerjee, Amitava;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Garal‐Pantaler, Elena;
    • Overbeek, Jetty;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Single-crystal two-dimensional material epitaxy on tailored non-single-crystal substrates.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29451-w
    By:
    • Li, Xin;
    • Wu, Guilin;
    • Zhang, Leining;
    • Huang, Deping;
    • Li, Yunqing;
    • Zhang, Ruiqi;
    • Li, Meng;
    • Zhu, Lin;
    • Guo, Jing;
    • Huang, Tianlin;
    • Shen, Jun;
    • Wei, Xingzhan;
    • Yu, Ka Man;
    • Dong, Jichen;
    • Altman, Michael S.;
    • Ruoff, Rodney S.;
    • Duan, Yinwu;
    • Yu, Jie;
    • Wang, Zhujun;
    • Huang, Xiaoxu
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36

    Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial.

    Published in:
    Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e216, doi. 10.1093/cid/ciac523
    By:
    • Tam, Anthony Raymond;
    • Zhang, Ricky Ruiqi;
    • Lung, Kwok-Cheung;
    • Liu, Raymond;
    • Leung, Ka-Yi;
    • Liu, Danlei;
    • Fan, Yujing;
    • Lu, Lu;
    • Lam, Athene Hoi-Ying;
    • Chung, Tom Wai-Hin;
    • Yip, Cyril Chik-Yan;
    • Lo, Jenny;
    • Wu, Alan Ka-Lun;
    • Lee, Rodney;
    • Sin, Simon;
    • Ng, Pauline Yeung;
    • Chan, Wai-Ming;
    • Shum, Hoi-Ping;
    • Yan, Wing-Wa;
    • Chan, Jasper Fuk-Woo
    Publication type:
    Article
    37

    Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.

    Published in:
    Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e822, doi. 10.1093/cid/ciab1041
    By:
    • Lu, Lu;
    • Mok, Bobo Wing Yee;
    • Chen, Lin Lei;
    • Chan, Jacky Man Chun;
    • Tsang, Owen Tak Yin;
    • Lam, Bosco Hoi Shiu;
    • Chuang, Vivien Wai Man;
    • Chu, Allen Wing Ho;
    • Chan, Wan Mui;
    • Ip, Jonathan Daniel;
    • Chan, Brian Pui Chun;
    • Zhang, Ruiqi;
    • Yip, Cyril Chik Yan;
    • Cheng, Vincent Chi Chung;
    • Chan, Kwok Hung;
    • Jin, Dong Yan;
    • Hung, Ivan Fan Ngai;
    • Yuen, Kwok Yung;
    • Chen, Honglin;
    • To, Kelvin Kai Wang
    Publication type:
    Article
    38

    Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.

    Published in:
    Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1623, doi. 10.1093/cid/ciab656
    By:
    • Chen, Lin-Lei;
    • Lu, Lu;
    • Choi, Charlotte Yee-Ki;
    • Cai, Jian-Piao;
    • Tsoi, Hoi-Wah;
    • Chu, Allen Wing-Ho;
    • Ip, Jonathan Daniel;
    • Chan, Wan-Mui;
    • Zhang, Ricky Ruiqi;
    • Zhang, Xiaojuan;
    • Tam, Anthony Raymond;
    • Lau, Daphne Pui-Ling;
    • To, Wing-Kin;
    • Que, Tak-Lun;
    • Yip, Cyril Chik-Yan;
    • Chan, Kwok-Hung;
    • Cheng, Vincent Chi-Chung;
    • Yuen, Kwok-Yung;
    • Hung, Ivan Fan-Ngai;
    • To, Kelvin Kai-Wang
    Publication type:
    Article
    39

    A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.

    Published in:
    Clinical Infectious Diseases, 2021, v. 73, n. 2, p. e304, doi. 10.1093/cid/ciaa804
    By:
    • Hung, Ivan Fan-Ngai;
    • Yap, Desmond Yat-Hin;
    • Yip, Terence Pok-Siu;
    • Zhang, Ricky Ruiqi;
    • To, Kelvin Kai-Wang;
    • Chan, Kwok-Hung;
    • Tang, Sydney Chi-Wai;
    • Lui, Sing-Leung;
    • Levin, Yotam;
    • Kochba, Efrat;
    • Lau, Johnson Yiu-Nam;
    • Yuen, Man-Fung;
    • Chan, Tak-Mao;
    • Yuen, Kwok-Yung
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults.

    Published in:
    Vaccines, 2023, v. 11, n. 4, p. 723, doi. 10.3390/vaccines11040723
    By:
    • Zhang, Ruiqi;
    • Chan, Kwok-Hung;
    • Wang, Pui;
    • Zhou, Runhong;
    • Yau, Henry Kwong-Chi;
    • Wong, Creany Ka-Wai;
    • Au, Meena Wai-Lam;
    • Tam, Anthony Raymond;
    • Ng, Chi-Tao;
    • Lou, Matthew Kwok-Chung;
    • Liu, Na;
    • Huang, Haode;
    • Deng, Shaofeng;
    • Tam, Rachel Chun-Yee;
    • Liu, Ying;
    • Long, Teng;
    • Tsoi, Hoi-Wah;
    • Ng, Miko K. W.;
    • Cai, Jian-Piao;
    • To, Kelvin Kai-Wang
    Publication type:
    Article
    46
    47
    48
    49
    50